Sort
39,280 grants matching “leukemia”
Human Acute Myeloid Leukemia Stem Cells
$366,225Ravindra Majeti · Stanford University · R01 · FY2020 · CA
The Role of ABC Transporters in Stem Cells
$366,188Brian P Sorrentino · St. Jude Children'S Research Hospital · R01 · FY2006 · HL
GABP Transcription Factor in Myeloid Differentiation
$366,188Alan G Rosmarin · Rhode Island Hospital · R01 · FY2006 · HL
CLINICAL TRIALS OF ALLOGENEIC STEM CELL TRANSPLANT IN LYMPHOHEMATOPOIETIC DISORDE
$366,186Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2011 · CA
Mistargeting of Elastase in Bone Marrow Failure
$366,180Marshall S. Horwitz · University Of Washington · R01 · FY2006 · HL
Reprogramming myeloid cells to inhibit cancer development
$366,170Chengcheng Zhang · Ut Southwestern Medical Center · R01 · FY2023 · CA
Development and Therapeutic Efficacy of a Novel Lactate Transporter inhibitor (MCT4) CB-202 in tumors that overexpress MCT4, such as Triple-Negative Breast Cancer (TNBC) and Acute Myeloid Leukemia (AL
$366,162Yong Wu · Charles R. Drew University Of Med & Sci · U54 · FY2024 · MD
Pathology and Biology of Leukemia Oncogenes
$366,152Stanford University · R01 · FY2004 · CA
Pathology and Biology of Leukemia Oncogenes
$366,118Michael L Cleary · Stanford University · R01 · FY2008 · CA
The Role of DLST in Leukemogenesis
$366,114Hui Feng · Boston University Medical Campus · R01 · FY2019 · CA
Acute Leukemia in the Elderly: Development of Novel, Targeted Therapeutics
$366,084Dan Longo · National Institute On Aging · Z01 · FY2008 · AG
Project 1: Clonal Dynamics Guiding Curative Therapies for Acute Myeloid Leukemia
$366,060David T Scadden · Dana-Farber Cancer Inst · U54 · FY2018 · CA
Hoxa9, Meis1, and Pbx in Self-renewal and Leukemogenesis
$366,047Mark P Kamps · University Of California, San Diego · R01 · FY2011 · CA
Collaborative Research: Ultrasensitive Cancer Biomarker Detection on Biophotonic Chips
$366,016Holger Schmidt · University Of California-Santa Cruz · · FY2012 · ENG
JAK/STAT signaling in the pathogenesis of DNMT3A mutant T-ALL
$366,013Grant Anthony Challen · Washington University · R01 · FY2021 · CA
Off-the-shelf engineered NK cells for the treatment of AML
$366,000Katy Rezvani · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Role of GAS41 in human cancer
$366,000Xiaobing Shi · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA
Mechanisms of targeting oncoprotein SET in tumor suppression
$366,000Wei Gu · Columbia University Health Sciences · R01 · FY2021 · CA
Estimating the Cost Trajectories and Projecting the Cost of Cancer Care in the United States: Methodology and Application
$366,000Liang Li · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Mechanisms of targeting oncoprotein SET in tumor suppression
$366,000Wei Gu · Columbia University Health Sciences · R01 · FY2017 · CA
Novel Strategies to Target Leukemia-Stromal Interactions
$366,000Peng Huang · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
Mechanisms of targeting oncoprotein SET in tumor suppression
$366,000Wei Gu · Columbia University Health Sciences · R01 · FY2020 · CA
Estimating the Cost Trajectories and Projecting the Cost of Cancer Care in the United States: Methodology and Application
$366,000Liang Li · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Novel Strategies to Target Leukemia-Stromal Interactions
$366,000Helene Pelicano · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA
The structural function of ATR in development, oncogenesis and cancer therapy
$366,000Shan Zha · Columbia University Health Sciences · R01 · FY2021 · CA